SusannaS.ParkMD

Ophthalmology • Sacramento, CA

Retinal Disease

Professor, Ophthalmology, UC, Davis School of Medicine

Join to view full profile

Dr. Park is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Park's full profile

Already have an account?

Office
4860 Y St
Suite 2400
Sacramento, CA 95817
Phone+1 916-734-6544

Fax+1 916-734-6197

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1989 - 1992
Yale-New Haven Medical CenterInternship, Internal Medicine, 1988 - 1989
Yale School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1992 - 2026
TX State Medical License 1994 - 1999
MA State Medical License 1992 - 1996
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Super Doctor SuperDoctors.com
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration Start of enrollment: 2007 May 01
Completed
Early Phase 1
ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) Start of enrollment: 2010 Sep 01
Completed
Phase 1, Phase 2
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy Start of enrollment: 2012 Jul 01
Active, not recruiting
Phase 1
Treatment of Central Retinal Vein Occlusion Using Stem Cells Study Start of enrollment: 2019 Oct 22
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

223 citations
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and compl...
Neil H. White, Wanjie Sun, Patricia A. Cleary, Ronald P. Danis, Matthew D. Davis
Archives of Ophthalmology. 2008-12-01
142 citations
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
Alex S. Willoughby, Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell Burns
Ophthalmology. 2015-09-01
130 citations
Retinal stem cell transplantation: Balancing safety and potential.
Mandeep S. Singh, Susanna Soon Chun Park, Thomas A. Albini, M. Valeria Canto-Soler, Henry Klassen
Progress in Retinal and Eye Research. 2020-03-01

Journal Articles

Preliminary observation of a Phase 1 Trial of Intravitreal bone marrow CD34+ cell therapy for ischemic and degenerative retinopathy
Park SS, Bauer G, Abedi M, et al, Invest Ophthalmol Vis Sci

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow